452 related articles for article (PubMed ID: 22617239)
1. New PET radiopharmaceuticals beyond FDG for brain tumor imaging.
Gulyás B; Halldin C
Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):173-90. PubMed ID: 22617239
[TBL] [Abstract][Full Text] [Related]
2. Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [
Eisazadeh R; Shahbazi-Akbari M; Mirshahvalad SA; Pirich C; Beheshti M
Semin Nucl Med; 2024 Mar; 54(2):293-301. PubMed ID: 38331629
[TBL] [Abstract][Full Text] [Related]
3. A Dual Tracer 18F-FCH/18F-FDG PET Imaging of an Orthotopic Brain Tumor Xenograft Model.
Fu Y; Ong LC; Ranganath SH; Zheng L; Kee I; Zhan W; Yu S; Chow PK; Wang CH
PLoS One; 2016; 11(2):e0148123. PubMed ID: 26844770
[TBL] [Abstract][Full Text] [Related]
4. The role of new PET tracers for lung cancer.
Szyszko TA; Yip C; Szlosarek P; Goh V; Cook GJ
Lung Cancer; 2016 Apr; 94():7-14. PubMed ID: 26973200
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive Stratification of Colon Cancer by Multiplex PET Imaging.
Malviya G; Lannagan TRM; Johnson E; Mackintosh A; Bielik R; Peters A; Soloviev D; Brown G; Jackstadt R; Nixon C; Gilroy K; Campbell A; Sansom OJ; Lewis DY
Clin Cancer Res; 2024 Apr; 30(8):1518-1529. PubMed ID: 38493804
[TBL] [Abstract][Full Text] [Related]
6. [The role of PET/CT in the central nervous system tumours].
Szabó P
Magy Onkol; 2023 Dec; 67(4):321-331. PubMed ID: 38109511
[TBL] [Abstract][Full Text] [Related]
7. The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy.
Galldiks N; Law I; Pope WB; Arbizu J; Langen KJ
Neuroimage Clin; 2017; 13():386-394. PubMed ID: 28116231
[TBL] [Abstract][Full Text] [Related]
8. PET Tracers Beyond FDG in Prostate Cancer.
Schuster DM; Nanni C; Fanti S
Semin Nucl Med; 2016 Nov; 46(6):507-521. PubMed ID: 27825431
[TBL] [Abstract][Full Text] [Related]
9. The Role of PET Imaging in Patients with Prion Disease: A Literature Review.
Mattoli MV; Giancipoli RG; Cocciolillo F; Calcagni ML; Taralli S
Mol Imaging Biol; 2024 Apr; 26(2):195-212. PubMed ID: 38302686
[TBL] [Abstract][Full Text] [Related]
10. Radiopharmaceutical and Eu
Shi X; Cao C; Zhang Z; Tian J; Hu Z
J Nanobiotechnology; 2021 Jul; 19(1):212. PubMed ID: 34271928
[TBL] [Abstract][Full Text] [Related]
11. MRI combined with PET-CT of different tracers to improve the accuracy of glioma diagnosis: a systematic review and meta-analysis.
Yang Y; He MZ; Li T; Yang X
Neurosurg Rev; 2019 Jun; 42(2):185-195. PubMed ID: 28918564
[TBL] [Abstract][Full Text] [Related]
12. Preclinical evaluation of 3-18F-fluoro-2,2-dimethylpropionic acid as an imaging agent for tumor detection.
Witney TH; Pisaneschi F; Alam IS; Trousil S; Kaliszczak M; Twyman F; Brickute D; Nguyen QD; Schug Z; Gottlieb E; Aboagye EO
J Nucl Med; 2014 Sep; 55(9):1506-12. PubMed ID: 25012458
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of
Somme F; Bender L; Namer IJ; Noël G; Bund C
Cancer Imaging; 2020 Oct; 20(1):70. PubMed ID: 33023662
[TBL] [Abstract][Full Text] [Related]
14. Atherosclerosis imaging using PET: Insights and applications.
Sriranjan RS; Tarkin JM; Evans NR; Le EPV; Chowdhury MM; Rudd JHF
Br J Pharmacol; 2021 Jun; 178(11):2186-2203. PubMed ID: 31517992
[TBL] [Abstract][Full Text] [Related]
15. Advancements and future directions in positron emission tomography-guided radiotherapy: a narrative review.
Mehta S; Yang C; Jadvar H; Colletti PM; Conti PS; Ma L; Chang EL; Ye JC
Chin Clin Oncol; 2024 Apr; 13(2):24. PubMed ID: 38711177
[TBL] [Abstract][Full Text] [Related]
16. PET Radiotracers in Atherosclerosis: A Review.
Blanchard I; Vootukuru N; Bhattaru A; Patil S; Rojulpote C
Curr Probl Cardiol; 2023 Nov; 48(11):101925. PubMed ID: 37392979
[TBL] [Abstract][Full Text] [Related]
17. Choline PET/CT in Multiple Myeloma.
Mesguich C; Hulin C; Lascaux A; Bordenave L; Marit G; Hindié E
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32481661
[TBL] [Abstract][Full Text] [Related]
18. The Validation Path of Hypoxia PET Imaging: Focus on Brain Tumours.
Quartuccio N; Asselin MC
Curr Med Chem; 2018; 25(26):3074-3095. PubMed ID: 29149829
[TBL] [Abstract][Full Text] [Related]
19. A Phase 0 Microdosing PET/CT Study Using O-[18F]Fluoromethyl-d-Tyrosine in Normal Human Brain and Brain Tumor.
Moon H; Byun BH; Lim I; Kim BI; Choi CW; Rhee CH; Lee KC; Woo SK; Park C; Kil HS; Chi DY; Youn SM; Lim SM
Clin Nucl Med; 2021 Sep; 46(9):717-722. PubMed ID: 34034333
[TBL] [Abstract][Full Text] [Related]
20. Can 18F-FDG PET/MRI Be Used as a Diagnostic Tool in Early Neuro-Behçet Disease?
Avanoğlu Güler A; Ataş N; Karadeniz H; Taner ME; Akdemir ÜÖ
J Clin Rheumatol; 2021 Dec; 27(8S):S717-S718. PubMed ID: 32897989
[No Abstract] [Full Text] [Related]
[Next] [New Search]
